Hiroyuki Ida Selected Research

Proteasome Inhibitors

1/2015	Proteasome Inhibitor Bortezomib Enhances the Activity of Multiple Mutant Forms of Lysosomal α-Glucosidase in Pompe Disease.
11/2011	Proteasome inhibitors improve the function of mutant lysosomal α-glucosidase in fibroblasts from Pompe disease patient carrying c.546G>T mutation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroyuki Ida Research Topics

Disease

14	Gaucher Disease (Gaucher's Disease) 04/2022 - 08/2004
12	Mucopolysaccharidosis II (Hunter Syndrome) 05/2021 - 01/2010
10	Glycogen Storage Disease Type II (Pompe's Disease) 01/2017 - 05/2010
9	Fabry Disease (Fabry's Disease) 06/2022 - 07/2008
7	Lysosomal Storage Diseases (Lysosomal Storage Disease) 05/2021 - 05/2014
7	Neoplasms (Cancer) 10/2016 - 10/2008
4	Mucopolysaccharidoses 04/2021 - 01/2010
4	Retinoblastoma (Glioblastoma, Retinal) 10/2016 - 08/2009
3	Seizures (Absence Seizure) 04/2022 - 07/2011
3	Fibrosis (Cirrhosis) 01/2020 - 01/2013
3	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2020 - 12/2015
3	Mucopolysaccharidosis I (Hurler Syndrome) 01/2018 - 06/2015
2	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 04/2022 - 01/2010
2	Drug-Related Side Effects and Adverse Reactions 01/2021 - 10/2014
2	Pathologic Constriction (Stenosis) 01/2021 - 11/2017
2	Infections 11/2019 - 01/2011
2	Hypertrophy 01/2018 - 11/2017
2	Body Weight (Weight, Body) 11/2017 - 01/2016
2	Febrile Seizures (Febrile Seizure) 01/2017 - 07/2011
2	Atrophy 01/2016 - 08/2012
2	Metabolic Diseases (Metabolic Disease) 12/2015 - 01/2015
2	Asthma (Bronchial Asthma) 07/2011 - 05/2010
2	Parkinson Disease (Parkinson's Disease) 09/2010 - 01/2007
2	Parkinsonian Disorders (Parkinsonism) 09/2010 - 01/2007
2	Sphingolipidoses (Sphingolipidosis) 05/2007 - 08/2004
1	Gliosis 06/2022
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 06/2022
1	Myoclonus (Nocturnal Myoclonus) 04/2022
1	Prostatic Neoplasms (Prostate Cancer) 03/2022
1	Inborn Genetic Diseases (Disease, Hereditary) 09/2021
1	Airway Obstruction (Choking) 05/2021
1	Congenital Abnormalities (Deformity) 04/2021
1	Phenylketonurias (Phenylketonuria) 01/2021
1	Supravalvular Aortic Stenosis (Aortic Supravalvular Stenosis) 01/2021
1	Maternal Phenylketonuria 01/2021
1	Hyperuricemia 01/2021
1	Juvenile gout 01/2021
1	Bronchiolitis Obliterans Syndrome 01/2020
1	Microsatellite Instability 01/2020
1	Esophageal Squamous Cell Carcinoma 01/2020
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2020
1	Glomerulonephritis 11/2019
1	Nephritis 11/2019
1	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 01/2019
1	Hyperplasia 01/2018
1	Aortic Valve Stenosis (Aortic Stenosis) 01/2018

Drug/Important Bio-Agent (IBA)

14	GlycosaminoglycansIBA 05/2021 - 09/2012
13	EnzymesIBA 06/2022 - 05/2007
10	GlucosidasesIBA 09/2021 - 11/2011
10	AcidsIBA 09/2021 - 07/2002
6	Pharmaceutical PreparationsIBA 04/2022 - 11/2011
6	Proteins (Proteins, Gene)FDA Link 11/2019 - 12/2007
4	Glucosylceramidase (Glucocerebrosidase)IBA 12/2021 - 01/2007
4	alpha-Galactosidase (Beano)IBA 01/2018 - 07/2008
4	GlycogenIBA 01/2017 - 05/2010
3	Glucose (Dextrose)FDA LinkGeneric 09/2021 - 09/2010
3	Iduronic Acid (Iduronate)IBA 12/2020 - 02/2016
3	GalactosidasesIBA 07/2019 - 05/2011
3	AntibodiesIBA 01/2017 - 10/2012
3	Vitamin D FDA LinkGeneric 04/2016 - 05/2010
2	eliglustatIBA 09/2021 - 01/2018
2	CreatinineIBA 01/2021 - 08/2014
2	globotriaosylceramide (globotriosylceramide)IBA 01/2017 - 07/2008
2	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2016 - 10/2013
2	Hemoglobins (Hemoglobin)IBA 01/2016 - 01/2016
2	Proteasome InhibitorsIBA 01/2015 - 11/2011
2	Cholecalciferol (Vitamin D3)FDA Link 02/2014 - 05/2010
2	human GAA protein (Myozyme)FDA Link 10/2012 - 05/2010
2	CytokinesIBA 01/2011 - 12/2007
2	Valproic Acid (Depakote)FDA LinkGeneric 10/2010 - 07/2009
2	N-octyl-beta-valienamineIBA 05/2007 - 08/2004
2	beta-GlucosidaseIBA 05/2007 - 08/2004
1	GlycosphingolipidsIBA 06/2022
1	perampanelIBA 04/2022
1	CeramidesIBA 09/2021
1	Glucosylceramides (Glucocerebrosides)IBA 09/2021
1	Iduronate SulfataseIBA 05/2021
1	Coenzymes (Enzyme Cofactors)IBA 01/2021
1	Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)IBA 01/2021
1	sapropterin (tetrahydrobiopterin)FDA Link 01/2021
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2021
1	UromodulinIBA 01/2021
1	Therapeutic UsesIBA 12/2020
1	GadoliniumIBA 01/2020
1	Lysergic Acid Diethylamide (LSD)IBA 01/2020
1	NucleotidesIBA 01/2020
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2020
1	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 11/2019
1	plasmin receptorIBA 11/2019
1	Mitochondrial Proton-Translocating ATPases (Mitochondrial ATP Synthase)IBA 01/2018
1	Heparin (Liquaemin)FDA LinkGeneric 01/2018

Therapy/Procedure

22	Enzyme Replacement Therapy 04/2022 - 12/2007
16	Therapeutics 04/2022 - 08/2004
5	Bone Marrow Transplantation (Transplantation, Bone Marrow) 11/2016 - 05/2011
2	Hematopoietic Stem Cell Transplantation 01/2020 - 01/2019
2	Radiotherapy 12/2013 - 10/2010
1	Activities of Daily Living (ADL) 04/2022
1	Castration 03/2022
1	Length of Stay 01/2021
1	Arterial Switch Operation 01/2021